^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Cizumab (bevacizumab biosimilar)

Associations
Trials
Company:
Hetero
Drug class:
VEGF-A inhibitor
Related drugs:
Associations
Trials